Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

ZFP36L1 negatively regulates plasmacytoid differentiation of BCL1 cells by targeting BLIMP1 mRNA.

Nasir A, Norton JD, Baou M, Zekavati A, Bijlmakers MJ, Thompson S, Murphy JJ.

PLoS One. 2012;7(12):e52187. doi: 10.1371/journal.pone.0052187. Epub 2012 Dec 20.

2.

Post-transcriptional regulation of BCL2 mRNA by the RNA-binding protein ZFP36L1 in malignant B cells.

Zekavati A, Nasir A, Alcaraz A, Aldrovandi M, Marsh P, Norton JD, Murphy JJ.

PLoS One. 2014 Jul 11;9(7):e102625. doi: 10.1371/journal.pone.0102625. eCollection 2014.

3.

ZFP36L1 negatively regulates erythroid differentiation of CD34+ hematopoietic stem cells by interfering with the Stat5b pathway.

Vignudelli T, Selmi T, Martello A, Parenti S, Grande A, Gemelli C, Zanocco-Marani T, Ferrari S.

Mol Biol Cell. 2010 Oct 1;21(19):3340-51. doi: 10.1091/mbc.E10-01-0040. Epub 2010 Aug 11.

4.

Differential expression and functional analysis of the tristetraprolin family during early differentiation of 3T3-L1 preadipocytes.

Lin NY, Lin TY, Yang WH, Wang SC, Wang KT, Su YL, Jiang YW, Chang GD, Chang CJ.

Int J Biol Sci. 2012;8(5):761-77. doi: 10.7150/ijbs.4036. Epub 2012 May 31.

5.

Myeloid ZFP36L1 does not regulate inflammation or host defense in mouse models of acute bacterial infection.

Hyatt LD, Wasserman GA, Rah YJ, Matsuura KY, Coleman FT, Hilliard KL, Pepper-Cunningham ZA, Ieong M, Stumpo DJ, Blackshear PJ, Quinton LJ, Mizgerd JP, Jones MR.

PLoS One. 2014 Oct 9;9(10):e109072. doi: 10.1371/journal.pone.0109072. eCollection 2014.

6.

ZFP36L1 promotes monocyte/macrophage differentiation by repressing CDK6.

Chen MT, Dong L, Zhang XH, Yin XL, Ning HM, Shen C, Su R, Li F, Song L, Ma YN, Wang F, Zhao HL, Yu J, Zhang JW.

Sci Rep. 2015 Nov 6;5:16229. doi: 10.1038/srep16229.

7.

Insulin increases tristetraprolin and decreases VEGF gene expression in mouse 3T3-L1 adipocytes.

Cao H, Urban JF Jr, Anderson RA.

Obesity (Silver Spring). 2008 Jun;16(6):1208-18. doi: 10.1038/oby.2008.65. Epub 2008 Apr 3.

8.

Production and characterization of ZFP36L1 antiserum against recombinant protein from Escherichia coli.

Cao H, Lin R, Ghosh S, Anderson RA, Urban JF Jr.

Biotechnol Prog. 2008 Mar-Apr;24(2):326-33. doi: 10.1021/bp070269n. Epub 2008 Feb 27.

9.

Chorioallantoic fusion defects and embryonic lethality resulting from disruption of Zfp36L1, a gene encoding a CCCH tandem zinc finger protein of the Tristetraprolin family.

Stumpo DJ, Byrd NA, Phillips RS, Ghosh S, Maronpot RR, Castranio T, Meyers EN, Mishina Y, Blackshear PJ.

Mol Cell Biol. 2004 Jul;24(14):6445-55.

10.

cAMP-dependent posttranscriptional regulation of steroidogenic acute regulatory (STAR) protein by the zinc finger protein ZFP36L1/TIS11b.

Duan H, Cherradi N, Feige JJ, Jefcoate C.

Mol Endocrinol. 2009 Apr;23(4):497-509. doi: 10.1210/me.2008-0296. Epub 2009 Jan 29.

11.

Maintenance of the marginal-zone B cell compartment specifically requires the RNA-binding protein ZFP36L1.

Newman R, Ahlfors H, Saveliev A, Galloway A, Hodson DJ, Williams R, Besra GS, Cook CN, Cunningham AF, Bell SE, Turner M.

Nat Immunol. 2017 Jun;18(6):683-693. doi: 10.1038/ni.3724. Epub 2017 Apr 10.

PMID:
28394372
12.

B lymphocyte-induced maturation protein 1 is a novel target gene of aryl hydrocarbon receptor.

Ikuta T, Ohba M, Zouboulis CC, Fujii-Kuriyama Y, Kawajiri K.

J Dermatol Sci. 2010 Jun;58(3):211-6. doi: 10.1016/j.jdermsci.2010.04.003. Epub 2010 Apr 18.

PMID:
20478695
13.

A role for Blimp1 in the transcriptional network controlling natural killer cell maturation.

Kallies A, Carotta S, Huntington ND, Bernard NJ, Tarlinton DM, Smyth MJ, Nutt SL.

Blood. 2011 Feb 10;117(6):1869-79. doi: 10.1182/blood-2010-08-303123. Epub 2010 Dec 3.

14.

The AP-1 transcription factor Fra1 inhibits follicular B cell differentiation into plasma cells.

Grötsch B, Brachs S, Lang C, Luther J, Derer A, Schlötzer-Schrehardt U, Bozec A, Fillatreau S, Berberich I, Hobeika E, Reth M, Wagner EF, Schett G, Mielenz D, David JP.

J Exp Med. 2014 Oct 20;211(11):2199-212. doi: 10.1084/jem.20130795. Epub 2014 Oct 6. Erratum in: J Exp Med. 2014 Oct 20;211(11):223.

15.

Targeted knockdown of the RNA-binding protein CRD-BP promotes cell proliferation via an insulin-like growth factor II-dependent pathway in human K562 leukemia cells.

Liao B, Patel M, Hu Y, Charles S, Herrick DJ, Brewer G.

J Biol Chem. 2004 Nov 19;279(47):48716-24. Epub 2004 Sep 8.

16.
17.

Novel binding of HuR and poly(C)-binding protein to a conserved UC-rich motif within the 3'-untranslated region of the androgen receptor messenger RNA.

Yeap BB, Voon DC, Vivian JP, McCulloch RK, Thomson AM, Giles KM, Czyzyk-Krzeska MF, Furneaux H, Wilce MC, Wilce JA, Leedman PJ.

J Biol Chem. 2002 Jul 26;277(30):27183-92. Epub 2002 May 13.

18.

Functional analysis of ZFP36 proteins in keratinocytes.

Prenzler F, Fragasso A, Schmitt A, Munz B.

Eur J Cell Biol. 2016 Aug;95(8):277-84. doi: 10.1016/j.ejcb.2016.04.007. Epub 2016 May 5.

PMID:
27182009
19.

ALY as a potential contributor to metastasis in human oral squamous cell carcinoma.

Saito Y, Kasamatsu A, Yamamoto A, Shimizu T, Yokoe H, Sakamoto Y, Ogawara K, Shiiba M, Tanzawa H, Uzawa K.

J Cancer Res Clin Oncol. 2013 Apr;139(4):585-94. doi: 10.1007/s00432-012-1361-5. Epub 2012 Dec 15.

PMID:
23242234
20.

A novel concept in antiangiogenic and antitumoral therapy: multitarget destabilization of short-lived mRNAs by the zinc finger protein ZFP36L1.

Planel S, Salomon A, Jalinot P, Feige JJ, Cherradi N.

Oncogene. 2010 Nov 11;29(45):5989-6003. doi: 10.1038/onc.2010.341. Epub 2010 Aug 30.

PMID:
20802528

Supplemental Content

Support Center